| 18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer SP Rowe, KL Gage, SF Faraj, KJ Macura, TC Cornish, ... Journal of Nuclear Medicine 56 (7), 1003-1010, 2015 | 239 | 2015 |
| Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma SF Faraj, E Munari, G Guner, J Taube, R Anders, J Hicks, A Meeker, ... Urology 85 (3), 703. e1-703. e6, 2015 | 185 | 2015 |
| Comprehensive evaluation of programmed death-ligand 1 expression in primary and metastatic prostate cancer MC Haffner, G Guner, D Taheri, GJ Netto, DN Palsgrove, Q Zheng, ... The American journal of pathology 188 (6), 1478-1485, 2018 | 160 | 2018 |
| T-cell infiltration and adaptive Treg resistance in response to androgen deprivation with or without vaccination in localized prostate cancer AZ Obradovic, MC Dallos, ML Zahurak, AW Partin, EM Schaeffer, AE Ross, ... Clinical Cancer Research 26 (13), 3182-3192, 2020 | 99 | 2020 |
| Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization M Holdhoff, G Guner, FJ Rodriguez, JL Hicks, Q Zheng, MS Forman, X Ye, ... Clinical Cancer Research 23 (12), 3150-3157, 2017 | 69 | 2017 |
| Utility of uroplakin II expression as a marker of urothelial carcinoma W Tian, G Guner, H Miyamoto, A Cimino-Mathews, N Gonzalez-Roibon, ... Human pathology 46 (1), 58-64, 2015 | 69 | 2015 |
| Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder LO Reis, D Taheri, A Chaux, G Guner, MAM Rodriguez, TJ Bivalacqua, ... Human pathology 47 (1), 20-25, 2016 | 61 | 2016 |
| High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma D Nguyen, D Taheri, S Springer, M Cowan, G Guner, ... Virchows Archiv 469, 427-434, 2016 | 53 | 2016 |
| High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder M Cowan, S Springer, D Nguyen, D Taheri, G Guner, MAM Rodriguez, ... Modern Pathology 29 (5), 511-515, 2016 | 44 | 2016 |
| The utility of STAT6 and ALDH1 expression in the differential diagnosis of solitary fibrous tumor versus prostate-specific stromal neoplasms G Guner, JA Bishop, SM Bezerra, D Taheri, DJ Zahavi, MAM Rodriguez, ... Human pathology 54, 184-188, 2016 | 40 | 2016 |
| Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder ML Cowan, S Springer, D Nguyen, D Taheri, G Guner, MAM Rodriguez, ... Human pathology 53, 8-13, 2016 | 40 | 2016 |
| Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations DN Palsgrove, D Taheri, SU Springer, M Cowan, G Guner, ... Human pathology 85, 1-9, 2019 | 39 | 2019 |
| Effective targeting of RNA polymerase I in treatment‐resistant prostate cancer JY Low, P Sirajuddin, M Moubarek, S Agarwal, A Rege, G Guner, H Liu, ... The Prostate 79 (16), 1837-1851, 2019 | 37 | 2019 |
| Tumor immune microenvironment in non–muscle-invasive urothelial carcinoma of the bladder ML Eich, A Chaux, G Guner, D Taheri, MAM Rodriguez, MDCR Pena, ... Human pathology 89, 24-32, 2019 | 29 | 2019 |
| Circulating tumor DNA as a marker of therapeutic response in patients with renal cell carcinoma: a pilot study MW Ball, MA Gorin, G Guner, PM Pierorazio, G Netto, CJ Paller, ... Clinical genitourinary cancer 14 (5), e515-e520, 2016 | 28 | 2016 |
| Indian ink vs tissue marking dye: a quantitative comparison of two widely used macroscopical staining tool K Kosemehmetoglu, G Guner, D Ates Virchows Archiv 457, 21-25, 2010 | 24 | 2010 |
| An immunohistochemical approach to detect oncogenic CTNNB1 mutations in primary neoplastic tissues A Akyol, G Güner, HS Özşeker, A Işık, Ö Atcı, S Uzun, E Atayar, F Ozaltin, ... Laboratory Investigation 99 (1), 128-137, 2019 | 22 | 2019 |
| Class III β-tubulin expression in colorectal neoplasms is a potential predictive biomarker for paclitaxel response S Öztop, A Işik, G Güner, H Gürdal, E Karabulut, E Yilmaz, A Akyol Anticancer Research 39 (2), 655-662, 2019 | 21 | 2019 |
| Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer B Ozbek, O Ertunc, A Erickson, ID Vidal, C Gomes‐Alexandre, G Guner, ... The Prostate 82 (6), 706-722, 2022 | 20 | 2022 |
| Tumour immune microenvironment in primary and metastatic papillary renal cell carcinoma ML Eich, A Chaux, MA Mendoza Rodriguez, G Guner, D Taheri, ... Histopathology 76 (3), 423-432, 2020 | 16 | 2020 |
